Effects of vitamin c supplementation on blood pressure: A meta-analysis of randomized controlled trials

American Journal of Clinical Nutrition

Volumn 95, Issue 5, 2012, Pages 1079-1088

  Juraschek, Stephen P ^a,b   Guallar, Eliseo ^a,b,c   Appel, Lawrence J ^a,b   Miller III, Edgar R ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; NITRIC OXIDE;

ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR FUNCTION; DIASTOLIC BLOOD PRESSURE; HUMAN; HYPERTENSION; META ANALYSIS; PUBLISHING; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; VITAMIN BLOOD LEVEL; VITAMIN METABOLISM; VITAMIN SUPPLEMENTATION;

ASCORBIC ACID; BLOOD PRESSURE; DIETARY SUPPLEMENTS; HUMANS; HYPERTENSION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMINS;

EID: 84860278737     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.111.027995     Document Type: Article

References (80)

1. World Health Organization. Guidelines on food fortification with micronutrients. 2006. Available from: http://www.who.int/nutrition/publications/ guide-food-fortification-micronutrients.pdf (cited February 2012).
2. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 1989;86:6377-81. (Pubitemid 19210655)
3. Jackson TS, Xu A, Vita JA, Keaney JF Jr. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res 1998;83:916-22. (Pubitemid 28503080)
4. Hoitink AWJH. [Research on the influence of vitamin C administration on the human organism, in particular in connection with the working capacity.] Verh Nederlands Inst Praevent 1946;4:62-3.
5. Yoshioka M, Aoyama K, Matsushita T. Effects of ascorbic acid on blood pressure and ascorbic acid metabolism in spontaneously hypertensive rats (SH rats). Int J Vitam Nutr Res 1985;55:301-7. (Pubitemid 15227664)
6. Ettarh RR, Odigie IP, Adigun SA. Vitamin C lowers blood pressure and alters vascular responsiveness in salt-induced hypertension. Can J Physiol Pharmacol 2002;80:1199-202. (Pubitemid 36249902)
7. Koh ET. Effect of vitamin C on blood parameters of hypertensive subjects. J Okla State Med Assoc 1984;77:177-82.
8. Feldman EB, Gold S, Greene J, Moran J, Xu G, Shultz GG, Hames CG, Feldman DS. Ascorbic acid supplements and blood pressure: a four-week pilot study. Ann N Y Acad Sci 1992;669:342-4. (Pubitemid 23009955)
9. Moran JP, Cohen L, Greene JM, Xu G, Feldman EB, Hames CG, Feldman DS. Plasma ascorbic acid concentrations relate inversely to blood pressure in human subjects. Am J Clin Nutr 1993;57:213-7. (Pubitemid 23039894)
10. McCarron DA, Morris CD, Henry HJ, Stanton JL. Blood pressure and nutrient intake in the United States. Science 1984;224:1392-8. (Pubitemid 14123336)
11. Farah R, Shurtz-Swirski R. The combined effect of calcium channel blocker Lercanidipine and antioxidants on low-grade systemic inflammation parameters in essential hypertension patients. Minerva Cardioangiol 2008;56:467-76.
12. Rodrigo R, Prat H, Passalacqua W, Araya J, Bachler JP. Decrease in oxidative stress through supplementation of vitamins C and E is associated with a reduction in blood pressure in patients with essential hypertension. Clin Sci (Lond) 2008;114:625-34. (Pubitemid 351596387)
13. Mahajan AS, Babbar R, Kansal N, Agarwal SK, Ray PC. Antihypertensive and antioxidant action of amlodipine and vitamin C in patients of essential hypertension. J Clin Biochem Nutr 2007;40:141-7. (Pubitemid 46623816)
14. Nightingale AK, Blackman DJ, Field R, Glover NJ, Pegge N, Mumford C, Schmitt M, Ellis GR, Morris-Thurgood JA, Frenneaux MP. Role of nitric oxide and oxidative stress in baroreceptor dysfunction in patients with chronic heart failure. Clin Sci (Lond) 2003;104:529-35. (Pubitemid 36628149)
15. Nightingale AK, Crilley JG, Pegge NC, Boehm EA, Mumford C, Taylor DJ, Styles P, Clarke K, Frenneaux MP. Chronic oral ascorbic acid therapy worsens skeletal muscle metabolism in patients with chronic heart failure. Eur J Heart Fail 2007;9:287-91. (Pubitemid 46330134)
16. Plantinga Y, Ghiadoni L, Magagna A, Giannarelli C, Franzoni F, Taddei S, Salvetti A. Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients. Am J Hypertens 2007;20:392-7. (Pubitemid 46442896)
17. Farvid MS, Jalali M, Siassi F, Hosseini M. Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes. Diabetes Care 2005;28:2458-64. (Pubitemid 41384294)
18. Farvid M, Homayoni F, Neyestani T, Amiri Z. Blood pressure lowering effects of micronutrients in type 2 diabetic patients. Iran J Endocrinology Metab 2010:12.
19. Hutchins AM, McIver IE, Johnston CS. Soy isoflavone and ascorbic acid supplementation alone or in combination minimally affect plasma lipid peroxides in healthy postmenopausal women. J Am Diet Assoc 2005;105:1134-7. (Pubitemid 40854205)
20. Ward NC, Hodgson JM, Croft KD, Burke V, Beilin LJ, Puddey IB. The combination of vitamin C and grape-seed polyphenols increases blood pressure: a randomized, double-blind, placebo-controlled trial. J Hypertens 2005;23:427-34. (Pubitemid 40279647)
21. Magen E, Viskoper R, Mishal J, Priluk R, Berezovsky A, Laszt A, London D, Yosefy C. Resistant arterial hypertension and hyperlipidemia: atorvastatin, not vitamin C, for blood pressure control. Isr Med Assoc J 2004;6:742-6. (Pubitemid 39646687)
22. Schutte AE, Huisman HW, Oosthuizen W, van Rooyen JM, Jerling JC. Cardiovascular effects of oral supplementation of vitamin C, E and folic acid in young healthy males. Int J Vitam Nutr Res 2004;74:285-93. (Pubitemid 39421010)
23. Block G, Dietrich M, Norkus EP. Effect of antioxidant supplementation on blood pressure: a randomized trial. Am J Epidemiol 2002;11(suppl):S22.
24. Darko D, Dornhorst A, Kelly FJ, Ritter JM, Chowienczyk PJ. Lack of effect of oral vitamin C on blood pressure, oxidative stress and endothelial function in type II diabetes. Clin Sci (Lond) 2002;103:339-44. (Pubitemid 35193236)
25. Mullan BA, Young IS, Fee H, McCance DR. Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes. Hypertension 2002;40:804-9. (Pubitemid 35434898)
26. Singh N, Graves J, Taylor PD, MacAllister RJ, Singer DR. Effects of a 'healthy' diet and of acute and long-term vitamin C on vascular function in healthy older subjects. Cardiovasc Res 2002;56:118-25. (Pubitemid 35247808)
27. Shargorodsky M, Debby O, Matas Z, Zimlichman R. Effect of long-term treatment with antioxidants (vitamin C, vitamin E, coenzyme Q10 and selenium) on arterial compliance, humoral factors and inflammatory markers in patients with multiple cardiovascular risk factors. Nutr Metab (Lond) 2010;7:55.
28. Brody S, Preut R, Schommer K, Schurmeyer TH. A randomized controlled trial of high dose ascorbic acid for reduction of blood pressure, cortisol, and subjective responses to psychological stress. Psychopharmacology (Berl) 2002;159:319-24. (Pubitemid 34143381)
29. Duffy SJ, Gokce N, Holbrook M, Hunter LM, Biegelsen ES, Huang A, Keaney JF Jr, Vita JA. Effect of ascorbic acid treatment on conduit vessel endothelial dysfunction in patients with hypertension. Am J Physiol Heart Circ Physiol 2001;280:H528-34.
30. Gaede P, Poulsen HE, Parving HH, Pedersen O. Double-blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in Type 2 diabetic patients. Diabet Med 2001;18:756-60. (Pubitemid 32955529)
31. Fotherby MD, Williams JC, Forster LA, Craner P, Ferns GA. Effect of vitamin C on ambulatory blood pressure and plasma lipids in older persons. J Hypertens 2000;18:411-5. (Pubitemid 30209722)
32. Title LM, Cummings PM, Giddens K, Genest JJ Jr, Nassar BA. Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease. J Am Coll Cardiol 2000;36:758-65.
33. Wang C, Li Y, Zhu K, Dong YM, Sun CH. Effects of supplementation with multivitamin and mineral on blood pressure and C-reactive protein in obese Chinese women with increased cardiovascular disease risk. Asia Pac J Clin Nutr 2009;18:121-30.
34. Keith RE, Driskell JA. Lung function and treadmill performance of smoking and nonsmoking males receiving ascorbic acid supplements. Am J Clin Nutr 1982;36:840-5. (Pubitemid 13214349)
35. Gokce N, Keaney JF Jr, Frei B, Holbrook M, Olesiak M, Zachariah BJ, Leeuwenburgh C, Heinecke JW, Vita JA. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1999;99:3234-40. (Pubitemid 29293432)
36. Galley HF, Thornton J, Howdle PD, Walker BE, Webster NR. Combination oral antioxidant supplementation reduces blood pressure. Clin Sci (Lond) 1997;92:361-5. (Pubitemid 27163093)
37. Ghosh SK, Ekpo EB, Shah IU, Girling AJ, Jenkins C, Sinclair AJ. A double-blind, placebo-controlled parallel trial of vitamin C treatment in elderly patients with hypertension. Gerontology 1994;40:268-72. (Pubitemid 24221038)
38. Salonen R, Korpela H, Nyyssönen K, Porkkala E, Salonen JT. Reduction of blood pressure by antioxidant supplementation: a randomised double-blind clinical trial. Life Chem Rep 1994;12:65-8.
39. Osilesi O, Trout DL, Ogunwole JO, Glover EE. Blood pressure and plasma lipids during ascorbic acid supplementation in borderline hypertensive and normotensive adults. Nutr Res 1991;11:405-12.
40. Evans M, Anderson RA, Smith JC, Khan N, Graham JM, Thomas AW, Morris K, Deely D, Frenneaux MP, Davies JS, et al. Effects of insulin lispro and chronic vitamin C therapy on postprandial lipaemia, oxidative stress and endothelial function in patients with type 2 diabetes mellitus. Eur J Clin Invest 2003;33:231-8. (Pubitemid 36411541)
41. Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, Dowdy AA, Marino EK, Bolson EL, Alaupovic P, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001;345:1583-92. (Pubitemid 33126837)
42. Kostis JB, Wilson AC, Lacy CR. Hypertension and ascorbic acid. Lancet 2000;355:1272; author reply 1273-4.
43. Upritchard JE, Sutherland WH, Mann JI. Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care 2000;23:733-8. (Pubitemid 30414184)
44. McAuliffe AV, Brooks BA, Fisher EJ, Molyneaux LM, Yue DK. Administration of ascorbic acid and an aldose reductase inhibitor (tolrestat) in diabetes: effect on urinary albumin excretion. Nephron 1998;80:277-84. (Pubitemid 28502316)
45. Klein F, Juhl B, Christiansen JS. Unchanged renal haemodynamics following high dose ascorbic acid administration in normoalbuminuric IDDM patients. Scand J Clin Lab Invest 1995;55:53-9.
46. Lovat LB, Lu Y, Palmer AJ, Edwards R, Fletcher AE, Bulpitt CJ. Double-blind trial of vitamin C in elderly hypertensives. J Hum Hypertens 1993;7:403-5. (Pubitemid 23243393)
47. el-Mostafa SD, Garner DD, Garrett L, Whaley RF, el-Sekate M, Kiker M. Beneficial effects of vitamin C on risk factors of cardiovascular diseases. J Egypt Public Health Assoc 1989;64:123-33.
48. Driskell JA, Herbert WG. Pulmonary function and treadmill performance of males receiving ascorbic acid supplements. Nutr Rep Int 1985;32:443-51. (Pubitemid 15240054)
49. Ness AR, Chee D, Elliott P. Vitamin C and blood pressure - an overview. J Hum Hypertens 1997;11:343-50. (Pubitemid 27354956)
50. McRae MP. Is vitamin C an effective antihypertensive supplement? A review and analysis of the literature. J Chiropr Med 2006;5:60-4.
51. Guelen I, Westerhof BE, Van Der Sar GL, Van Montfrans GA, Kiemeneij F, Wesseling KH, Bos WJ. Finometer, finger pressure measurements with the possibility to reconstruct brachial pressure. Blood Press Monit 2003;8:27-30. (Pubitemid 36343968)
52. Keith RE, Driskell JA. Effects of chronic cigarette smoking on vitamin C status, lung function, and resting and exercise cardiovascular metabolism in humans. Nutr Rep Int 1980;21:907-12. (Pubitemid 10014505)
53. Hercberg S, Preziosi P, Briancon S, Galan P, Triol I, Malvy D, Roussel AM, Favier A. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study - design, methods, and participant characteristics. SUpplementation en VItamines et Mineraux AntioXydants. Control Clin Trials 1998;19:336-51. (Pubitemid 28355758)
54. Trowman R, Dumville JC, Torgerson DJ, Cranny G. The impact of trial baseline imbalances should be considered in systematic reviews: a methodological case study. J Clin Epidemiol 2007;60:1229-33. (Pubitemid 350061144)
55. Egger M, Davey Smith G, Altman DG, eds. Systematic reviews in health care: meta-analysis in context. Chapter 15. London, United Kingdom: BMJ Publishing Group, 1995;289.
56. Levine M, Wang Y, Padayatty SJ, Morrow J. A new recommended dietary allowance of vitamin C for healthy young women. Proc Natl Acad Sci USA 2001;98:9842-6. (Pubitemid 32769391)
57. Woodgate DE, Conquer JA. Effects of a stimulant-free dietary supplement on body weight and fat loss in obese adults: a six-week exploratory study. Curr Ther Res Clin Exp 2003;64:248-62. (Pubitemid 36688216)
58. van Mierlo LA, Houben AJ, van der Knaap HC, Koning MM, Kloek J, de Leeuw PW. The effect of vitamins and minerals enriched milk on blood pressure in mildly hypertensive subjects. J Hum Hypertens 2008;22:54-6. (Pubitemid 350269257)
59. Galán AI, Palacios E, Ruiz F, Diez A, Arji M, Almar M, Moreno C, Calvo JI, Munoz ME, Delgado MA, et al. Exercise, oxidative stress and risk of cardiovascular disease in the elderly: protective role of antioxidant functional foods. Biofactors 2006;27:167-83. (Pubitemid 44434941)
60. Eriksson J, Kohvakka A. Magnesium and ascorbic acid supplementation in diabetes mellitus. Ann Nutr Metab 1995;39:217-23.
61. Block G, Mangels AR, Norkus EP, Patterson BH, Levander OA, Taylor PR. Ascorbic acid status and subsequent diastolic and systolic blood pressure. Hypertension 2001;37:261-7. (Pubitemid 32199085)
62. Rolla G, Brussino L, Carra R, Garbella E, Bucca C. Hypertension and ascorbic acid. Lancet 2000;355:1271-2; author reply 1273-4.
63. Hajjar IM, George V, Sasse EA, Kochar MS. A randomized, double-blind, controlled trial of vitamin C in the management of hypertension and lipids. Am J Ther 2002;9:289-93.
64. Deucher GP. Antioxidant therapy in the aging process. EXS 1992;62:428-37.
65. Zureik M, Galan P, Bertrais S, Mennen L, Czernichow S, Blacher J, Ducimetiere P, Hercberg S. Effects of long-term daily low-dose supplementation with antioxidant vitamins and minerals on structure and function of large arteries. Arterioscler Thromb Vasc Biol 2004;24:1485-91. (Pubitemid 39050445)
66. Mark SD, Wang W, Fraumeni JF Jr, Li JY, Taylor PR, Wang GQ, Dawsey SM, Li B, Blot WJ. Do nutritional supplements lower the risk of stroke or hypertension? Epidemiology 1998;9:9-15. (Pubitemid 28030484)
67. Mark SD, Wang W, Fraumeni JF Jr, Li JY, Taylor PR, Wang GQ, Guo W, Dawsey SM, Li B, Blot WJ. Lowered risks of hypertension and cerebrovascular disease after vitamin/mineral supplementation: the Linxian Nutrition Intervention Trial. Am J Epidemiol 1996;143:658-64. (Pubitemid 26111079)
68. Miller ER III, Appel LJ, Levander OA, Levine DM. The effect of antioxidant vitamin supplementation on traditional cardiovascular risk factors. J Cardiovasc Risk 1997;4:19-24. (Pubitemid 27286098)
69. Kim MK, Sasaki S, Sasazuki S, Okubo S, Hayashi M, Tsugane S. Lack of long-term effect of vitamin C supplementation on blood pressure. Hypertension 2002;40:797-803. (Pubitemid 35434897)
70. May JM. How does ascorbic acid prevent endothelial dysfunction? Free Radic Biol Med 2000;28:1421-9. (Pubitemid 30621484)
71. Solzbach U, Hornig B, Jeserich M, Just H. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation 1997;96:1513-9. (Pubitemid 27375345)
72. Huang A, Vita JA, Venema RC, Keaney JF Jr. Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. J Biol Chem 2000;275:17399-406. (Pubitemid 30430776)
73. Suematsu N, Ojaimi C, Recchia FA, Wang Z, Skayian Y, Xu X, Zhang S, Kaminski PM, Sun D, Wolin MS, et al. Potential mechanisms of low-sodium diet-induced cardiac disease: superoxide-NO in the heart. Circ Res 2010;106:593-600.
74. Silvestro A, Scopacasa F, Oliva G, de Cristofaro T, Iuliano L, Brevetti G. Vitamin C prevents endothelial dysfunction induced by acute exercise in patients with intermittent claudication. Atherosclerosis 2002;165:277-83. (Pubitemid 35333354)
75. Grebe M, Eisele HJ, Weissmann N, Schaefer C, Tillmanns H, Seeger W, Schulz R. Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J Respir Crit Care Med 2006;173:897-901.
76. McNulty PH, Robertson BJ, Tulli MA, Hess J, Harach LA, Scott S, Sinoway LI. Effect of hyperoxia and vitamin C on coronary blood flow in patients with ischemic heart disease. J Appl Physiol 2007;102:2040-5. (Pubitemid 46701938)
77. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007;297:842-57. (Pubitemid 46333949)
78. Cook NR, Albert CM, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, Buring JE, Manson JE. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from theWomen's Antioxidant Cardiovascular Study. Arch Intern Med 2007;167:1610-8. (Pubitemid 47280341)
79. Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JE, Glynn RJ, Gaziano JM. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 2008;300:2123-33.
80. Ness AR, Khaw KT, Bingham S, Day NE. Vitamin C status and blood pressure. J Hypertens 1996;14:503-8. (Pubitemid 26161101)